NR568 / NR 568 Midterm Exam (Latest 2024 / 2025): Advanced Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner |Latest Questions and Verified Answers - Chamberlain
NR568 / NR 568 Midterm Exam (Latest 2024 / 2025): Advanced Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner |Latest Questions and Verified Answers - Chamberlain • What are some high-risk patients with Lopinavir? A. Liver disease, anemia, renal function, bleeding disorders, infection B. Risk for hematologic toxicity is increased by a low granulocyte count, low levels of hemoglobin, Vt B12, or folic acid, and concurrent use of drugs that are myelosuppressive, nephrotoxic or toxic to circulating blood cells. C. Contraindications for full-term infants until 14 days after birth, and preterm infants until 14 days after their predicted birth date. D. Risk for pancreatitis is increased with a history of alcoholism or pancreatitis and by use of IV pentamidine. E. Liver impairment, neonates should not be prescribed formulations containing benzyl alcohol or its derivatives. - Correct Answer C What is the treatment for Tinea Pedis (athletes feet): a. Topical Azole
Geschreven voor
- Instelling
- NR 568 Advanced Pharmacology For The AGPCN (NR568
- Vak
- NR 568 Advanced Pharmacology For The AGPCN (NR568
Documentinformatie
- Geüpload op
- 7 maart 2025
- Aantal pagina's
- 26
- Geschreven in
- 2024/2025
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
nr 568 midterm exam
-
nr 568 advanced pharmacology for the agpcn nr568
-
advanced pharmacology for the adult gerontology pr
-
what are some high risk patients with lopinavi
-
nr568 nr 568 midterm exam lates